title: Role of lipoic acid on insulin resistance and leptin in experimentally diabetic rats.
abstract: OBJECTIVE
  We aimed to examine the changes in serum insulin and leptin levels in induced type 1 diabetes mellitus in relationship to glycemic state and lipid profiles and to clarify the role of lipoic acid (LA).
  
  
  METHODS
  Ninety-six male rats were equally divided into the following: a control group (normal, nondiabetic), a diabetic group induced by subcutaneous injection of alloxan (non-LA-treated), and an LA-treated diabetic group (for 4 weeks). Body weight, serum lipid profile, glucose, insulin, homeostasis model assessment-insulin resistance (HOMA-IR), and leptin were measured.
  
  
  RESULTS
  This study showed a significant increase in serum triacylglycerol (TG), total cholesterol, glucose levels, and HOMA-IR and a significant decrease in body weight gain, insulin, and leptin levels in the diabetic group compared to the control group. LA treatment induced a significant decrease in glucose, TG, and total cholesterol levels and significantly increased serum insulin and leptin levels in comparison with the diabetic group.
  
  
  CONCLUSIONS
  Induced diabetes resulted in insulin resistance, hyperlipidemia, and hypoleptinemia, while LA ameliorates these changes and improves insulin sensitivity.
authors.affiliation: Biochemistry Department, Faculty of Veterinary Medicine, Beni Suef University, Egypt.
authors.forename: Mohammed A
authors.initials: MA
authors.lastname: Kandeil
authors.forename: Kamal A
authors.initials: KA
authors.lastname: Amin
authors.forename: Kamel A
authors.initials: KA
authors.lastname: Hassanin
authors.forename: Kalid M
authors.initials: KM
authors.lastname: Ali
authors.forename: Eman T
authors.initials: ET
authors.lastname: Mohammed
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D003921:Diabetes Mellitus, Experimental / Q000097:blood* / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D020738:Leptin / Q000097:blood*; D008297:Male; D051381:Rats; D008063:Thioctic Acid / Q000008:administration & dosage*; D014280:Triglycerides / Q000097:blood; D015430:Weight Gain / Q000187:drug effects
chemical_list: D001786:Blood Glucose; D007328:Insulin; D020738:Leptin; D014280:Triglycerides; D008063:Thioctic Acid; D002784:Cholesterol